Advanced Search
Search Results
6557 total results found
125 - 6C42 Disorders due to use of synthetic cannab
6C42 Disorders due to use of synthetic cannabinoids 443 Disorders due to substance use or addictive behaviours of alcohol use disorders shows substantial regional variation; the highest prevalence is observed in eastern Europe and the lowest in Africa. Low pre...
126 - 6C43 Disorders due to use of opioids
6C43 Disorders due to use of opioids
127 - 6C44 Disorders due to use of sedatives, hypno
6C44 Disorders due to use of sedatives, hypnotics or anxiolytics Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders behaviour). Synthetic cannabinoid intoxication may therefore present more frequent...
128 - 6C45 Disorders due to use of cocaine
6C45 Disorders due to use of cocaine
129 - 6C46 Disorders due to use of stimulants, incl
6C46 Disorders due to use of stimulants, including amfetamines, methamfetamine and methcathinone
13 - 8A05.00 Tourette syndrome
8A05.00 Tourette syndrome Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders Tourette syndrome Essential (required) features • The presence of both motor tics and phonic tics that may or may not man...
130 - 6C47 Disorders due to use of synthetic cathin
6C47 Disorders due to use of synthetic cathinones 445 Disorders due to substance use or addictive behaviours Disorders due to use of cocaine Disorders due to use of cocaine are characterized by the pattern and consequences of cocaine use. Cocaine is a compound...
131 - 6C48 Disorders due to use of caffeine
6C48 Disorders due to use of caffeine
132 - 6C49 Disorders due to use of hallucinogens
6C49 Disorders due to use of hallucinogens
133 - 6C4A Disorders due to use of nicotine
6C4A Disorders due to use of nicotine Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders Disorders due to use of caffeine Disorders due to use of caffeine are characterized by the pattern and conseq...
134 - 6C4B Disorders due to use of volatile inhalan
6C4B Disorders due to use of volatile inhalants
135 - 6C4C Disorders due to use of MDMA or related
6C4C Disorders due to use of MDMA or related drugs, including MDA
136 - 6C4D Disorders due to use of dissociative dru
6C4D Disorders due to use of dissociative drugs, including ketamine and phencyclidine (PCP) 447 Disorders due to substance use or addictive behaviours Disorders due to use of volatile inhalants Disorders due to use of volatile inhalants are characterized by th...
137 - 6C4E Disorders due to use of other specified
6C4E Disorders due to use of other specified psychoactive substances, including medications
138 - 6C4F Disorders due to use of multiple specifi
6C4F Disorders due to use of multiple specified psychoactive substances, including medications
139 - 6C4G Disorders due to use of unknown or unspe
6C4G Disorders due to use of unknown or unspecified psychoactive substances
14 - 8A05.01 Chronic motor tic disorder
8A05.01 Chronic motor tic disorder
140 - 6C4H Disorders due to use of non psychoactive
6C4H Disorders due to use of non-psychoactive substances